|
Experimental model | Supplements (probiotics) | Key results | References |
|
LS513 cells | Live or inactive L. acidophilus, L. casei (1 × 106–1 × 109 CFU/mL), and 5-fluorouracil (5-FU, 100 µg/ml) | Dose-dependent enhancement of apoptotic activity of 5-FU. Exposure of 108 CFU/mL ↑ apoptotic efficiency (40%) ↑ activation of caspase-3 ↓ p21 expression | [22] |
|
HCT-116 cells | CFS from L. casei and L. rhamnosus GG (25% v/v) | ↓ cell invasion ↓ MMP-9 ↑ ZO-1 | [23] |
|
HGC-27, and DLD-1 cells | Live or heat-killed L. paracasei IMPC2.1 and L. rhamnosus GG (1 × 108 CFU/ml) | Inhibited cell growth and induced apoptosis | [24] |
|
CaCo-2 cells | CFS (5, 10, 20%) and bacterial extract (1, 5%) of L. acidophilus ATCC 4356 and L. casei ATCC 39392 | ↓ cell proliferation, migration, and invasion ↑ apoptosis | [25] |
|
5-FU-resistant HT-29 and HCT-116 cells | L. plantarum CFS (10 μg) and 5-FU (50 μM) | ↓ expression of CD44, CD133, CD166, and ALDH1 ↑ caspase-3 activity ↓ Wnt/β-catenin signaling ↓ size and formation of colonospheres | [26] |
|
HT-29 cells | CFS or metabolites of Propionibacterium freudenreichii ITG P9 with TRAIL and ITG P9-mediated fermented milk with TRAIL | ↑ proapoptotic gene expression ↓ antiapoptotic gene expression, TRAIL-R1/DR4, TRAIL-R2/DR5, and caspase-dependent proapoptotic activity | [27] |
|
HT-29 cells | CFS and cells of Lactobacillus strains (L. brevis PM150, L. plantarum PM153, L. brevis PM177, L. delbrueckii subsp. bulgarius BCRC10696, L. reuteri BCRC14625, L. salivarius BCRC14759, and L. johnsonii BCRC17010) | ↑ nitric oxide secretion ↑ proapoptosis ↑ lactate dehydrogenase and inhibited the growth of HT-29 cells | [28] |
|
CaCo-2 cells | L. acidophilus ATCC 314 and L. fermentum NCIMB 5221 | ↓ cell proliferation ↑ apoptosis | [29] |
|
HT-29, and Caco-2 cells | Methanolic extract of metabolites of Pichia kudriavzevii AS-12 (65 and 75 μg/ml) | Cytotoxic to cancer cells ↑ apoptosis | [30] |
|
HT-29 cells | CFS from Saccharomyces cerevisiae | ↑ PTEN, Caspas3 expression and ↓ Bclxl and RelA expression at 24 h posttreatment ↓ cell growth | [31] |
|
Human colonic smooth muscle strips | CFS, live cells and microbial fractions of L. acidophilus HB56003, S. thermophilus HB5621, E. faecalis HB62001, and B. longum HB55020. | Inhibited the contractility of colonic smooth muscle strips | [32] |
|